Repare Therapeutics, Inc.
(NASDAQ : RPTX)

( )
Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Daily Pre-Market Movers
Receive our daily pre-market mover email, free.
100% secure: your email is never shared, and you may opt out at any time.
...
Health Technology » Pharmaceuticals Major
symbolcompany%chnglast%shortavg$volume
MRKMerck & Co., Inc. 2.50%79.080.7%$1570.50m
JNJJohnson & Johnson 3.09%165.070.7%$1008.03m
PFEPfizer Inc. 1.76%42.050.9%$932.97m
ABBVAbbVie, Inc. 0.33%107.781.9%$684.15m
BMYBristol-Myers Squibb Co. 1.00%57.511.0%$657.88m
LLYEli Lilly & Co. 0.93%241.191.1%$614.99m
AZNAstraZeneca Plc 1.80%60.361.0%$372.91m
NVSNovartis AG 1.04%83.200.2%$176.17m
GSKGlaxoSmithKline Plc 1.73%39.320.2%$162.74m
RGENRepligen Corp. 1.71%268.286.8%$119.97m
NVONovo Nordisk A/S 1.55%105.030.1%$92.03m
VTRSViatris, Inc. 0.01%13.490.0%$90.57m
EDSAEdesa Biotech, Inc. 6.85%8.270.0%$75.72m
SNYSanofi 0.17%48.110.2%$62.98m
CRVSCorvus Pharmaceuticals, Inc. 3.46%4.780.7%$58.45m

Company Profile

Repare Therapeutics, Inc. engages in the research, development, and commercialization of precision oncology drugs targeting specific vulnerabilities of tumors in genetically defined patient populations. The company was founded by Daniel Durocher, Agnel Sfeir and Frank Sicheri on September 6, 2016 and is headquartered in Saint-Laurent, Canada.